AvalonRX | Healthcare Products, PGx, GLP-1 & Peptide Solutions
AvalonRX

Affordable Healthcare Products
Personalized Medication Solutions
Better Access to Care

AvalonRX brings together healthcare products, healthcare services, personalized medication support, pharmacogenetic solutions, digital health access, and a streamlined GLP-1 and peptide model designed to help consumers and organizations pursue better outcomes with greater confidence.

What AvalonRX Offers

A broader healthcare platform focused on affordability, support, innovation, and smarter treatment planning.

  • Healthcare products and medical-support solutions
  • Healthcare services and medication guidance
  • Mobile tools and telehealth-friendly access
  • PGx and personalized medication insight
  • GLP-1 and peptide access through a structured supply model
  • AI, analytics, and systems-of-care innovation
Core Offerings

Products & Services That Support Better Health

AvalonRX publicly positions itself around affordable healthcare products, healthcare services, technology-driven convenience, PGx support, medication cost awareness, and improved healthcare delivery systems.

01

Healthcare Products

A broad range of healthcare products, from over-the-counter items to more specialized health-support solutions.

02

Healthcare Services

Services may include consultations, medication guidance, prescription support, and wellness-focused assistance.

03

Mobile & Telehealth Access

AvalonRX highlights digital tools that help users manage medications, book appointments, and connect more easily with care.

04

Medication Cost Strategies

The platform also emphasizes practical ways to reduce medication costs and improve access to more efficient treatment paths.

05

AI & Research Positioning

Avalon messaging includes AI, analytics, and research-driven approaches intended to improve healthcare decision support.

06

System-Level Improvement

Avalon also speaks to improved delivery systems, stakeholder collaboration, and better outcomes across individual and population health.

GLP-1 & Peptide Model

A New Approach to GLP-1 and Peptide Access

AvalonRX presents a GLP/Peptide model in which compounded GLP-1s and peptides can be ordered and stocked through a standard 3PL and wholesale framework, designed to centralize product access and simplify ongoing fulfillment.

One-Call Program Simplified sourcing and centralized coordination
Partnered with a 50 state licensed FDA approved wholesalers with Track & Trace visibility, pedigree, supply confidence and 3PL
Timely Fulfillment Reliable operations for growing programs
Reasonable MOQs Flexible purchasing and scalable support

GLP-1 Product Options

AvalonRX’s public GLP/Peptide content highlights a growing set of compounded GLP-1 offerings.

  • GLP-1 formulations
  • Addition of B12
  • Addition of B6
  • Additive-free options
  • Lyophilized product options
  • Additional products coming

Peptide Product Options

The current public AvalonRX page also references peptide offerings that can support broader program flexibility.

  • Sermorelin
  • Glutathione
  • NAD+
  • Additional peptide products coming

Why Lyophilized Products Matter

  • Easy to ship
  • Long BUD potential
  • Easy to mix
  • Great pricing potential

Program Benefits

Avalon positions this model as a more centralized source for compounded GLP-1s and peptides, built around product consistency, green-sheeted APIs, fulfillment efficiency, and operational simplicity.

Consistency Green Sheet APIs Track & Trace Timely Fulfillment One-Stop Shopping Scalable Access
PGx & Precision Medicine

Personalized Medication Guidance, Research Insight, and Better Treatment Planning

AvalonRX and Avalon Behavioral Health Solutions both emphasize pharmacogenetics, mental health DNA research, pharmaceutical research, and the goal of more personalized medication decisions that can improve effectiveness while reducing avoidable adverse reactions and trial-and-error prescribing.

PGX

Pharmacogenetic Testing

Personalized testing designed to help guide medication choices, dosage planning, and treatment strategy.

DNA

Mental Health DNA Research

Genetic insight applied to psychiatric medication response and individualized mental-health-related treatment planning.

R&D

Pharmaceutical Research

PGx-related research can support how medications are developed, studied, and prescribed.

AI

AI & Advanced Technologies

Avalon also presents itself as using newer AI and data-driven technologies to improve health solutions and decision support.

Why AvalonRX

What Sets AvalonRX Apart

Built Around Affordability and Support

AvalonRX positions itself around affordable healthcare access and strong customer support, with a focus on helping people navigate medications, services, and better treatment pathways.

  • Affordable healthcare products
  • Customer-first service model
  • Healthcare convenience and access
  • Technology-enabled experience

Focused on Better Outcomes

The broader Avalon platform also speaks to improved healthcare delivery, population-health-oriented thinking, and the value of more coordinated systems of care including social determinants of health support.

  • Personalized medication decisions
  • Polypharmacy awareness
  • System redesign and collaboration
  • Individual and population health focus
Contact AvalonRX

Ready to Explore a Better Healthcare Experience?

Use this section as your lead-capture block for healthcare products, PGx testing, GLP-1/peptide inquiries, partnerships, or general support.

This form uses mailto: and opens the visitor’s email application addressed to mark.smith@avalonbhs.com. For a true web form, connect it to a backend or WordPress form plugin.

Healthcare System Reform and Social Determinants of Health

The current healthcare delivery system is not creating the optimal health outcomes.  Over decades the methodology has evolved to clinically driven interventions with a focus on a volume of care.  Often the overutilization of institutional treatment is the norm when a lessor location of care would drive better outcome. The challenge before us is to bring those non-clinical Social Determinants of Health (SDoH) interventions to individuals to prevent unnecessary utilization of the Emergency Department and in-patient hospitalization.

Avalon possess both strategic and operational experience in SDoH systems.  Key stakeholders in an effective model include:

  • Community Based Organizations
  • Faith Based Organizations
  • Housing Providers
  • Nutrition/Food Providers
  • Transportation Providers
  • Local governments
  • State Governments
  • Payers

Many of these groups agree on the ultimate outcome of care best being delivered at the lowest and closest level to the individual.  However, they need to tackle challenges of capacity, finance systems, budgeting, billing, documentation, and sustainability.
Avalon is available to work with you to maximize the value of redesigned Systems of Care and maximize quality and value at the organizational level.

Subsribe To Our Newsletter

Stay in touch with us to get latest news and special offers.

Address

20 Mayfair Lane, Williamsville, New York 14221

Call Us

+1 716 359 5839